Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTFA.L Regulatory News (CTFA)

  • There is currently no data for CTFA

Update

30 Sep 2011 17:51

RNS Number : 3673P
Avia Health Informatics PLC
30 September 2011
 

Avia Health Informatics PLC

30 September 2011

Avia Health Informatics Plc

("Avia" or the "Company")

Update

Further to the announcement of 30 August, 2011, Avia (AIM: AVIA), the AIM-listed developer and provider of clinical decision support systems, provides the following update.

Audit work on the results for financial year ended (FYE) 31 March 2011 is approaching completion, but is now expected to be completed with results released within the next three weeks. The Company's current cash resources remain tightly constrained, but recent trading and management of working capital have enabled the Company to continue trading. The Company will give a further update on its financial condition and current trading at the time of its results, or sooner if appropriate.

Based on draft accounts, there is no change to the Company's expectations as previously communicated, namely to report for FYE March 2011:

a) revenue in the order of GBP2.1 million, an increase of approximately 20% compared to the previous year (broadly in line with expectations of GBP 2.2 million), and

b) an operating loss before any impairment of intangible assets and non-recurring items of c. GBP500k (compared with c. GBP300k market expectations, reflecting both the small revenue shortfall vs. expectations of GBP2.2m and higher than expected market development costs.

The Company intends to give an update on its expectations for the financial year ended 31 March 2012 at or shortly before the confirmation of its audited results for FYE March 2011.

The Company's primary business objective remains to develop, market and sell a range of products for use in the UK and international markets, and Avia is actively seeking strategic investment from partners able to distribute its products and services internationally.

In order to provide a more stable base for future growth, the Board is continuing to seek additional external funding. The Board continues to believe, based on current trading, that it is appropriate to seek additional funding of c. GBP1 million as a working capital reserve and to fund growth. While there can be no certainty at this time as to the availability of additional funding, the Board continues to examine all funding options available to the Company. Approaches have been received and/or solicited from potentially interested parties, to whom the Company expects to provide initial information for further discussion.

In addition, the Company has been approached by parties interested in acquiring the principal operating business held by the group, including its intellectual property, with whom it is also engaging.

The Board is seeking to evaluate all such approaches, whether oriented towards funding or the purchase of its operating assets, with a view to seeking to maximise shareholder value.

The Company will give a further update on its financial condition and working capital on publication of its audited results for FYE March 2011 referred to above, and will make further announcements as appropriate.

The shares will remain suspended pending release of its annual audited accounts and further clarification of the Company's financial position.

##Ends##

Enquiries:

Avia Health Informatics Plc Tel. +44 (0) 1494 618 503

Barry Giddings, Chairman

 

Panmure Gordon (UK) Limited Tel. +44 (0) 20 7459 3600

Aubrey Powell, Corporate Finance

Adam Pollock, Corporate Broking

 

About Avia Health Informatics Plc

Avia is a developer and provider of clinical decision support systems. Its Odyssey product range is used by clinicians and non-clinicians in various environments around the world to provide effective healthcare support, increasing the levels of patient care while delivering operational efficiencies. The delivery of Odyssey can be in a static or mobile environment from a PC, laptop, tablet or mobile device, with clinical content, training and services delivered via the web. The groups other product, PathFinderRF offers on-line referral facilitation to manage the quality of referrals.

Avia's partners provide market reach into geographies outside of the UK, including the United States and Australia.

The Odyssey range is built on a common medical content database which has been developed over the past 15 years. Odyssey is continually updated, tailored with question and answer sets and has a user interface adapted for the particular user groups and the environment in which it is used.

Environments include prisons, ships, call centres, GP out of hours, walk in centres, care homes, pharmacies and other clinical and non-clinical environments.

For more information on Avia please visit: www.ahi-plc.com and the Odyssey product range: www.odyssey-cdss.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDCSSXBGBG
Date   Source Headline
24th Apr 20157:00 amRNSCessation of trading on AIM
17th Apr 201510:07 amRNSStatement re Suspension
18th Dec 201410:33 amRNSHalf Yearly Report
25th Nov 201412:00 pmRNSUpdate on investments and strategy
31st Oct 201411:34 amRNSResult of AGM
24th Oct 20147:30 amRNSSuspension - Cientifica Plc
23rd Oct 20141:26 pmRNSUpdate on investments and suspension of shares
8th Oct 20143:30 pmRNSDirectorate change and notice of AGM
30th Sep 20146:30 pmRNSTotal Voting Rights
30th Sep 20146:30 pmRNSFinal Results
4th Sep 20147:31 amRNSBoard Changes
29th Aug 20147:00 amRNSInvestment in G Heat Limited
31st Jul 20142:30 pmRNSTotal Voting Rights
25th Jul 20147:00 amRNSIssue of Equity
17th Jul 20142:00 pmRNSBusiness Update
13th Jun 20147:00 amRNSDevelopment Agreement with Perpetuus Carbon Group
16th May 201411:15 amRNSRainmaker Agreement Update
11th Apr 20147:00 amRNSOption to Invest in Graphene Company Agreed
14th Mar 20145:15 pmRNSDirector Declaration
11th Mar 20147:00 amRNSProposed Placing
26th Feb 201411:30 amRNSDirector Declaration
5th Feb 201411:00 amRNSSignificant Shareholder Declaration
4th Feb 20145:00 pmRNSDirector Declaration
3rd Feb 20144:32 pmRNSNotification of major interest in shares
30th Jan 201411:00 amRNSGrant of Share Options
24th Jan 20149:00 amRNSDirector Declaration
20th Jan 201412:15 pmRNSNotification of major interest in shares
15th Jan 20144:31 pmRNSNotification of major interest in shares
13th Jan 201412:00 pmRNSNotification of major interest in shares
9th Jan 20145:20 pmRNSNotification of major interest in shares
8th Jan 20144:45 pmRNSNotification of major interest in shares
7th Jan 201411:00 amRNSExclusivity Agreement Signed
2nd Jan 20143:00 pmRNSLetter to shareholders
31st Dec 201310:27 amRNSHolding(s) in Company
11th Dec 20137:00 amRNSNotification of major interest in shares
9th Dec 20139:30 amRNSNotification of major interest in shares
6th Dec 20137:00 amRNSInterim Results
3rd Dec 20134:34 pmRNSNotification of Major Interest
3rd Dec 20134:30 pmRNSNotification of Major Interest
3rd Dec 20134:28 pmRNSNotification of Major Interest
3rd Dec 20134:25 pmRNSNotification of Major Interest
22nd Nov 20139:09 amRNSNotification of major interest in shares
21st Nov 20132:25 pmRNSResult of AGM
15th Nov 20139:00 amRNSNotification of Major Interest
11th Nov 20139:04 amRNSNotification of Major Interest
8th Nov 20137:00 amRNSCEO appointed Change of Name
6th Nov 20139:06 amRNSNotification of Major Interest
4th Nov 201310:45 amRNSNotification of major interest in shares
1st Nov 20135:30 pmRNSNotification of major interest in shares
30th Oct 20137:00 amRNSAdditional Monies Raised

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.